Advisors Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Advisors Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,075	Closed	-$122K	–	1638
2018 Q3	$122K	Sell	6,075 -240	-4%	-$5.46K	﹤0.01%	1328
2018 Q2	$123K	Sell	6,315 -299	-5%	-$6.62K	﹤0.01%	1320
2018 Q1	$139K	Sell	6,614 -26	-0.4%	-$440	﹤0.01%	1282
2017 Q4	$88K	Buy	6,640 +152	+2%	+$2.29K	﹤0.01%	1351
2017 Q3	$120K	Sell	6,488 -266	-4%	-$4.96K	﹤0.01%	1319
2017 Q2	$124K	Sell	6,754 -177	-3%	-$3.51K	﹤0.01%	1343
2017 Q1	$156K	Buy	6,931 +5,005	+260%	+$120K	﹤0.01%	1335
2016 Q4	$67K	Buy	+1,926	New	+$57.5K	﹤0.01%	1627

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisors Asset Management's AMAG Position: Q4 2018 in Review

Advisors Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 6,075 shares — an estimated $122K sold.

Advisors Asset Management first reported a position in AMAG in Q4 2016 and held it in 8 quarters. The position peaked at $156K in Q1 2017. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

Advisors Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Advisors Asset Management sold 6,075 AMAG Pharmaceuticals shares in Q4 2018, an estimated $122K.
Advisors Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 8 quarters.
Advisors Asset Management's AMAG Pharmaceuticals position peaked at $156K in Q1 2017.
190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Advisors Asset Management's 13F filing for Q4 2018, filed 31 Jan 2019.